CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
It's kitted out with CCTV cameras, allowing the team to monitor the animal's behaviour.
，更多细节参见同城约会
Follow topics & set alerts with myFT
DTF St. Louis' structure is infuriating.